Key result
MASLD links to severe vasomotor symptoms, but the association disappears after BMI adjustment.
Why the study?
Is metabolic dysfunction-associated steatotic liver disease diagnosis associated with severe vasomotor symptoms in midlife women?
Cross-Sectional (n=4,599)
Yes
Is metabolic dysfunction-associated steatotic liver disease diagnosis associated with severe vasomotor symptoms in midlife women?
Answers are grounded in this paper and cite their sources.
The association between MASLD and severe vasomotor symptoms in midlife women is not independent and appears to be driven by shared risk factors such as BMI and hypertension.
OBJECTIVE: Metabolic dysfunction-associated steatotic liver disease (MASLD) and vasomotor symptoms (VMS) are associated with increased cardiovascular disease risk. Although visceral adiposity has been linked to MASLD and VMS independently, this study aimed to evaluate associations between the two in midlife women. METHODS: A cross-sectional study of women aged 45-60 years receiving primary care at one of four sites was conducted from March 1 through June 30, 2021. MASLD diagnosis was obtained utilizing the International Classification of Diseases , Ninth Revision and Tenth Revision codes. VMS burden was evaluated with the Menopause Rating Scale and categorized as severe/very severe versus none/mild/moderate. Logistic regression models were used to assess the association between VMS and diagnosed MASLD both univariately and after individually adjusting for several risk factors. RESULTS: A total of 4,599 women were included in the final analysis, 304 (7%) of whom had an MASLD diagnosis. On univariate analysis, women with an MASLD diagnosis were more likely to have severe/very severe VMS (odds ratio [OR], 1.50; 95% CI, 1.08-2.08; P = 0.015). However, the association between MASLD diagnosis and severe/very severe VMS was no longer statistically significant after individually adjusting for body mass index (adjusted OR, 1.36; 95% CI, 0.97-1.92) and hypertension (adjusted OR, 1.38; 95% CI, 0.99-1.93). CONCLUSIONS: The relationship between MASLD and VMS appears to be best explained by other variables including BMI and hypertension. Although they do not appear to be directly linked, given the prevalence of bothersome VMS in midlife women, addressing VMS may enable greater adherence to lifestyle modifications as part of MASLD management.
No takes yet. Share an insight, caveat, or question.
Aldhaleei et al. (2024) conducted a cross-sectional in Metabolic dysfunction-associated steatotic liver disease (MASLD) and vasomotor symptoms (n=4,599). Metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis vs. No MASLD diagnosis was evaluated on Severe/very severe vasomotor symptoms (VMS) (OR 1.50, 95% CI 1.08-2.08, p=0.015). MASLD diagnosis was associated with severe vasomotor symptoms, but the association was no longer significant after adjusting for BMI.
Synapse has enriched 10 related papers. Consider them for comparative context: